Verified Peptide ReviewLast reviewed: 23 April 2026
Compound Profile · Metabolic
Tesofensine
Tesofensine is a synthetic compound studied in research as a triple monoamine reuptake inhibitor for metabolic and weight-loss effects.
LegalResearch onlyEvidenceModerateHuman useNot approved
7.6/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Clinical-stage metabolic agent with promising early efficacy data. Safety profile requires careful monitoring.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Moderate evidence — replication still building
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Tesofensine review
A triple monoamine reuptake inhibitor.
Studied for appetite suppression and weight loss through dopamine, serotonin and noradrenaline effects.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.